Dopamine D3 receptor deletion or blockade attenuates cocaineinduced conditioned place preference in mice

Neuropharmacology

Volumn 72, Issue , 2013, Pages 82-87

  Song, Rui ^a,b   Zhang, Hai Ying ^a   Peng, Xiao Qing ^a   Su, Rui Bin ^b   Yang, Ri Fang ^b   Li, Jin ^b   Xi, Zheng Xiong ^a   Gardner, Eliot L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Cocaine; Conditioned place preference; Dopamine; Reward; YQA 14

Indexed keywords

COCAINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; UNCLASSIFIED DRUG; YQA 14; BENZOXAZOLE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; PIPERAZINE DERIVATIVE; YQA14;

ADDICTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RECEPTOR BLOCKING; DOSE RESPONSE; DRUG SELECTIVITY; DRUG SELF ADMINISTRATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; REWARD; SINGLE DRUG DOSE; TREATMENT DURATION; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; ANTAGONISTS AND INHIBITORS; DEFICIENCY; DRUG EFFECTS;

ANIMALS; BENZOXAZOLES; COCAINE; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PIPERAZINES; RECEPTORS, DOPAMINE D3;

EID: 84884825434     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.04.042     Document Type: Article

References (36)

1. Accili, D., Fishburn, C.S., Drago, J., Steiner, H., Lachowicz, J.E., Park, B.H., Gauda, E.B., Lee, E.J., Cool, M.H., Sibley, D.R., Gerfen, C.R., Westphal, H., Fuchs, S., 1996. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. U. S. A. 93, 1945-1949. (Pubitemid 26079860)
2. Beaulieu, J.M., Gainetdinov, R.R., 2011. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182-217.
3. Boulay, D., Depoortere, R., Rostene, W., Perrault, G., Sanger, D.J., 1999. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice. Neuropharmacology 38, 555-565. (Pubitemid 29088233)
4. Bouthenet, M.L., Souil, E., Martres, M.P., Sokoloff, P., Giros, B., Schwartz, J.C., 1991. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564, 203-219.
5. Caine, S.B., Koob, G.F., 1993. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260, 1814-1816.
6. Caine, S.B., Koob, G.F., 1995. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. 6, 333-347.
7. Caine, S.B., Koob, G.F., Parsons, L.H., Everitt, B.J., Schwartz, J.C., Sokoloff, P., 1997. D3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuroreport 8, 2373-2377. (Pubitemid 27319704)
8. Caine, S.B., Negus, S.S., Mello, N.K., Patel, S., Bristow, L., Kulagowski, J., Vallone, D., Saiardi, A., Borrelli, E., 2002. Role of dopamine D2-like receptors in cocaine selfadministration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J. Neurosci. 22, 2977-2988. (Pubitemid 37465846)
9. Caine, S.B., Thomsen, M., Barrett, A.C., Collins, G.T., Grundt, P., Newman, A.H., Butler, P., Xu, M., 2012. Cocaine self-administration in dopamine D(3) receptor knockout mice. Exp. Clin. Psychopharmacol. 20, 352-363.
10. Caine, S.B., Thomsen, M., Gabriel, K.I., Berkowitz, J.S., Gold, L.H., Koob, G.F., Tonegawa, S., Zhang, J., Xu, M., 2007. Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J. Neurosci. 27, 13140-13150. (Pubitemid 350220494)
11. Chen, L., Xu, M., 2010. Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking. J. Neurochem. 114, 530-541.
12. Diaz, J., Levesque, D., Lammers, C.H., Griffon, N., Martres, M.P., Schwartz, J.C., Sokoloff, P., 1995. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65, 731-745.
13. Fuchs, R.A., Tran-Nguyen, L.T., Weber, S.M., Khroyan, T.V., Neisewander, J.L., 2002. Effects of 7-OH-DPAT on cocaine-seeking behavior and on re-establishment of cocaine self-administration. Pharmacol. Biochem. Behav. 72, 623-632. (Pubitemid 34450862)
14. Holmes, A., Lachowicz, J.E., Sibley, D.R., 2004. Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 47, 1117-1134. (Pubitemid 39572704)
15. Kong, H., Kuang,W., Li, S., Xu, M., 2011. Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine. Neuroscience 176, 152-161.
16. Lamas, X., Negus, S.S., Nader, M.A., Mello, N.K., 1996. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology (Berl.) 124, 306-314. (Pubitemid 26149915)
17. Le Foll, B., Frances, H., Diaz, J., Schwartz, J.C., Sokoloff, P., 2002. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur. J. Neurosci. 15, 2016-2026. (Pubitemid 35471890)
18. Levesque, D., Diaz, J., Pilon, C., Martres, M.P., Giros, B., Souil, E., Schott, D., Morgat, J.L., Schwartz, J.C., Sokoloff, P., 1992. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N, N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. U. S. A. 89, 8155-8159.
19. Mash, D.C., 1997. D3 receptor binding in human brain during cocaine overdose. Mol. Psychiatry 2, 5-6.
20. Mash, D.C., Staley, J.K., 1999. D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims. Ann. N. Y. Acad. Sci. 877, 507-522. (Pubitemid 29351876)
21. Nader, M.A., Mach, R.H., 1996. Self-administration of the dopamine D3 agonist 7- OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology (Berl.) 125, 13-22. (Pubitemid 26156633)
22. Neisewander, J.L., Fuchs, R.A., Tran-Nguyen, L.T., Weber, S.M., Coffey, G.P., Joyce, J.N., 2004. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 29, 1479-1487. (Pubitemid 38982240)
23. Pugsley, T.A., Davis, M.D., Akunne, H.C., MacKenzie, R.G., Shih, Y.H., Damsma, G., Wikstrom, H., Whetzel, S.Z., Georgic, L.M., Cooke, L.W., et al., 1995. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275, 1355-1366. (Pubitemid 26130641)
24. Seeman, P., Van Tol, H.H., 1994. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15, 264-270. (Pubitemid 24210734)
25. Sokoloff, P., Giros, B., Martres, M.P., Andrieux, M., Besancon, R., Pilon, C., Bouthenet, M.L., Souil, E., Schwartz, J.C., 1992. Localization and function of the D3 dopamine receptor. Arzneimittelforschung 42, 224-230.
26. Song, R., Yang, R.F., Wu, N., Su, R.B., Li, J., Peng, X.Q., Li, X., Gaal, J., Xi, Z.X., Gardner, E.L., 2012a. YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptorknockout mice. Addict. Biol. 17, 259-273.
27. Song, R., Zhang, H.Y., Li, X., Bi, G.H., Gardner, E.L., Xi, Z.X., 2012b. Increased vulnerability to cocaine in mice lacking dopamine D3 receptors. Proc. Natl. Acad. Sci. U. S. A. 109, 17675-17680.
28. Spealman, R.D., 1996. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 278, 1128-1137. (Pubitemid 27166962)
29. Staley, J.K., Mash, D.C., 1996. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J. Neurosci. 16, 6100-6106. (Pubitemid 26313985)
30. Sulzer, D., 2011. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628-649.
31. Vorel, S.R., Ashby Jr., C.R., Paul, M., Liu, X., Hayes, R., Hagan, J.J., Middlemiss, D.N., Stemp, G., Gardner, E.L., 2002. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 22, 9595-9603. (Pubitemid 35356201)
32. Wise, R.A., 1996. Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243-251. (Pubitemid 26168484)
33. Xi, Z.X., Gilbert, J.G., Pak, A.C., Ashby Jr., C.R., Heidbreder, C.A., Gardner, E.L., 2005. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variablepayoff fixed-ratio cocaine self-administration in rats. Eur. J. Neurosci. 21, 3427-3438. (Pubitemid 40961437)
34. Xi, Z.X., Newman, A.H., Gilbert, J.G., Pak, A.C., Peng, X.Q., Ashby Jr., C.R., Gitajn, L., Gardner, E.L., 2006. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drugseeking behavior in rats. Neuropsychopharmacology 31, 1393-1405.
35. Xu, M., Koeltzow, T.E., Cooper, D.C., Tonegawa, S., White, F.J., 1999. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse 31, 210-215. (Pubitemid 29063291)
36. Xu, M., Koeltzow, T.E., Santiago, G.T., Moratalla, R., Cooper, D.C., Hu, X.T., White, N.M., Graybiel, A.M., White, F.J., Tonegawa, S., 1997. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19, 837-848. (Pubitemid 27471388)